Şükran Yılmaz

870 total citations
31 papers, 721 citations indexed

About

Şükran Yılmaz is a scholar working on Molecular Biology, Biomaterials and Organic Chemistry. According to data from OpenAlex, Şükran Yılmaz has authored 31 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Biomaterials and 7 papers in Organic Chemistry. Recurrent topics in Şükran Yılmaz's work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (5 papers) and Ferrocene Chemistry and Applications (4 papers). Şükran Yılmaz is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (5 papers) and Ferrocene Chemistry and Applications (4 papers). Şükran Yılmaz collaborates with scholars based in Türkiye and India. Şükran Yılmaz's co-authors include Zelihagül Değim, Handan Yılmaz, Levent Altıntaş, Meltem Dartar Öztan, Turgut Topal, İsmail Tuncer Değim, Ahmet Nacar, Dinç Eşsiz, Gülfem Ergün and Ferhan Eğilmez and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmaceutical Sciences and Biomedicine & Pharmacotherapy.

In The Last Decade

Şükran Yılmaz

31 papers receiving 705 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Şükran Yılmaz Türkiye 16 185 166 130 119 118 31 721
Madhu Verma India 13 228 1.2× 181 1.1× 69 0.5× 175 1.5× 270 2.3× 44 823
Ruchadaporn Kaomongkolgit Thailand 16 157 0.8× 337 2.0× 89 0.7× 106 0.9× 140 1.2× 38 895
Rajan Swami India 16 365 2.0× 293 1.8× 62 0.5× 166 1.4× 208 1.8× 38 849
Sarita Kumari Yadav India 18 173 0.9× 242 1.5× 45 0.3× 122 1.0× 325 2.8× 30 892
Sevda Jafari Iran 15 205 1.1× 179 1.1× 63 0.5× 237 2.0× 39 0.3× 30 874
A. Yekta Özer Türkiye 19 244 1.3× 293 1.8× 49 0.4× 265 2.2× 123 1.0× 47 795
Tu Huang China 7 127 0.7× 147 0.9× 76 0.6× 100 0.8× 26 0.2× 9 467
R Parikh India 6 166 0.9× 61 0.4× 65 0.5× 93 0.8× 86 0.7× 10 542
Minli Xie China 15 250 1.4× 136 0.8× 97 0.7× 193 1.6× 60 0.5× 28 739
Maria Perde‐Schrepler Romania 17 171 0.9× 67 0.4× 88 0.7× 183 1.5× 41 0.3× 42 948

Countries citing papers authored by Şükran Yılmaz

Since Specialization
Citations

This map shows the geographic impact of Şükran Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şükran Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şükran Yılmaz more than expected).

Fields of papers citing papers by Şükran Yılmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şükran Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şükran Yılmaz. The network helps show where Şükran Yılmaz may publish in the future.

Co-authorship network of co-authors of Şükran Yılmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Şükran Yılmaz. A scholar is included among the top collaborators of Şükran Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şükran Yılmaz. Şükran Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yılmaz, Şükran, et al.. (2020). Development of effective AmB/AmB–αCD complex double loaded liposomes using a factorial design for systemic fungal infection treatment. Journal of Liposome Research. 31(2). 177–188. 9 indexed citations
3.
Yücel, Çiğdem, et al.. (2019). Novel Approach to the Treatment of Diabetes: Embryonic Stem Cell and Insulin-Loaded Liposomes and Nanocochleates. Journal of Nanoscience and Nanotechnology. 19(7). 3706–3719. 10 indexed citations
4.
Değim, Zelihagül, et al.. (2019). Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma. Drug Development Research. 80(5). 556–565. 24 indexed citations
5.
Yılmaz, Şükran, et al.. (2019). Evaluation of biorelevant media to investigate the dissolution properties on flurbiprofen and to assess cytotoxicity effects on Caco-2 cell line. Istanbul Journal of Pharmacy. 48(3). 82–88. 2 indexed citations
6.
Demirbolat, Gülen Melike, Levent Altıntaş, Şükran Yılmaz, & İsmail Tuncer Değim. (2018). Development of Orally Applicable, Combinatorial Drug–Loaded Nanoparticles for the Treatment of Fibrosarcoma. Journal of Pharmaceutical Sciences. 107(5). 1398–1407. 22 indexed citations
8.
Yücel, Çiğdem, Yeşim Aktaş, Zelihagül Değim, et al.. (2018). Effects of Insulin and Embryonic Stem Cells loaded PLGA Nanoparticles on Pancreatic Beta TC Cells. Acta Poloniae Pharmaceutica - Drug Research. 75(6). 1377–1389. 1 indexed citations
9.
Eren, Gökçen, Şükran Yılmaz, & Fatma Gümüş. (2017). In Vitro Cytotoxic Activities of Platinum(II) Complex with 1-Methyl-2-(3'- hydroxypropyl)benzimidazole and 2-(3'-Hydroxypropyl)benzimidazolium Hexa- and Tetrachloroplatinate Salts. Letters in Drug Design & Discovery. 15(1). 65–69. 5 indexed citations
10.
Küçüktürkmen, Berrin, et al.. (2016). Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells. Drug Development and Industrial Pharmacy. 43(1). 12–21. 34 indexed citations
11.
Değim, Zelihagül, et al.. (2015). The Effectiveness of Raloxifene-Loaded Liposomes and Cochleates in Breast Cancer Therapy. AAPS PharmSciTech. 17(4). 968–977. 45 indexed citations
12.
Değim, Zelihagül, et al.. (2014). Antitumoral and MMP-2 inhibition activity of raloxifene or tamoxifen loaded nanoparticles containing dimethyl-β-cyclodextrin. Journal of Inclusion Phenomena and Macrocyclic Chemistry. 80(1-2). 31–36. 3 indexed citations
13.
Yücel, Çiğdem, Zelihagül Değim, & Şükran Yılmaz. (2013). Nanoparticle and liposome formulations of doxycycline: Transport properties through Caco-2 cell line and effects on matrix metalloproteinase secretion. Biomedicine & Pharmacotherapy. 67(6). 459–467. 23 indexed citations
14.
Ergün, Gülfem, Ferhan Eğilmez, & Şükran Yılmaz. (2011). Effect of reduced exposure times on the cytotoxicity of resin luting cements cured by high-power led. Journal of Applied Oral Science. 19(3). 286–292. 25 indexed citations
15.
Değim, Zelihagül, et al.. (2011). New perspective for the treatment of Alzheimer diseases: Liposomal rivastigmine formulations. Drug Development and Industrial Pharmacy. 37(7). 775–789. 63 indexed citations
16.
Ilbasmiş-Tamer, Sibel, Şükran Yılmaz, Erden Banoğlu, & İsmail Tuncer Değim. (2010). Carbon Nanotubes to Deliver Drug Molecules. Journal of Biomedical Nanotechnology. 6(1). 20–27. 40 indexed citations
17.
Yılmaz, Handan, et al.. (2008). In vitro evaluation of cytotoxicity of soft lining materials on L929 cells by MTT assay. Journal of Biomedical Materials Research Part B Applied Biomaterials. 90B(1). 82–86. 94 indexed citations
18.
Bal, Bilge Turhan, Handan Yılmaz, Cemal Aydın, Seçil Karakoca, & Şükran Yılmaz. (2008). In vitro cytotoxicity of maxillofacial silicone elastomers: Effect of accelerated aging. Journal of Biomedical Materials Research Part B Applied Biomaterials. 89B(1). 122–126. 14 indexed citations
19.
Ergün, Gülfem, et al.. (2007). Effect of light curing type on cytotoxicity of dentine‐bonding agents. International Endodontic Journal. 40(3). 216–223. 26 indexed citations
20.
Öztan, Meltem Dartar, et al.. (2003). A comparison of the in vitro cytotoxicity of two root canal sealers. Journal of Oral Rehabilitation. 30(4). 426–429. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026